The Federal Commerce Fee is investigating Amazon’s $3.9 billion acquisition of the first well being group One Medical, a transfer that might delay the completion of the deal.
Each One Medical and Amazon acquired a request for extra data Friday in reference to an FTC assessment of the merger, in response to a submitting made with securities regulators by One Medical’s father or mother, San Francisco-based 1Life Healthcare Inc.
Amazon introduced plans in late July to purchase One Medical, a concierge-type medical service with roughly 190 medical places of work in 25 markets. Final week, the e-commerce large stated it could shutter its personal hybrid digital in-home care service known as Amazon Care, a One Medical competitor, as a result of it wasn’t assembly clients’ wants.
The One Medical deal, the primary to be introduced below CEO Andy Jassy, was one other push into healthcare for Amazon following its acquisition of the net pharmacy PillPack for $750 million in 2018. Teams calling for stricter antitrust laws shortly urged the FTC to dam the merger, arguing it could additional increase the corporate’s large market energy.
An Amazon spokesperson declined to remark.
The FTC has already been investigating the sign-up and cancellation practices of Amazon Prime and has issued civil subpoenas in that case.
Final 12 months, the corporate requested unsuccessfully that FTC Chair Lina Khan step apart from separate antitrust investigations into its enterprise, arguing she can be biased. Khan was notable critic of Seattle-based Amazon and different Massive Tech corporations previous to assuming the chairmanship. As a Yale regulation scholar in 2017, she wrote an influential research titled “Amazon’s Antitrust Paradox.”